Skip to content
Clinical Trials – home

Testosterone deficiency syndrome Treatment

Clinical trials for Testosterone deficiency syndrome

Recruiting trials first

See all 3 trials →
Quick filters

3 clinical trials in this condition

Bioavailability, Safety and Tolerability of elinzanetant (BAY 3427080) in Healthy Adults for Treatment of Vasomotor Symptoms

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG

Relative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG

Study on How Elinzanetant Affects Dabigatran Etexilate in Healthy Volunteers with Vasomotor Symptoms

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Dabigatran Etexilate
  • Sponsor:Bayer AG
See all 3 trials →filters applied: condition = Testosterone deficiency syndrome

In short

Testosterone deficiency syndrome occurs when the body doesn't produce enough testosterone, leading to symptoms that can significantly affect quality of life, from reduced energy and muscle strength to changes in sexual function and mood.

Key points

  • Testosterone deficiency diagnosis requires both consistently low blood testosterone levels (typically below 300 ng/dL) measured on at least two morning blood tests and the presence of clear symptoms affecting quality of life.
  • Treatment goals focus on relieving symptoms like reduced sexual function, low energy, muscle loss, and mood changes rather than simply normalizing lab values.
  • Multiple testosterone replacement options exist including patches, gels, injections, and implantable pellets, each with different application schedules and side effect profiles.
  • Sometimes addressing underlying causes like obesity, diabetes, sleep apnea, or medication side effects can restore testosterone naturally without replacement therapy.
  • Testosterone therapy carries potential risks including cardiovascular complications, increased red blood cell counts, fertility reduction, and prostate concerns, requiring careful monitoring throughout treatment.
  • Regular follow-up with blood tests to monitor testosterone levels, red blood cell counts, and prostate-specific antigen is essential for safe, effective treatment.
  • The condition is significantly underdiagnosed despite affecting up to 9.5% of middle-aged men and up to 30% of diabetic or obese men, with less than 10% receiving treatment.
  • Men with certain conditions including prostate cancer, recent heart problems, severe sleep apnea, or plans to father children soon should not receive testosterone therapy.

Understanding Treatment Goals and Approaches

Treating testosterone deficiency syndrome focuses on restoring testosterone levels to a healthy range and relieving symptoms that impact daily life. The main goals include improving sexual function, increasing energy levels, maintaining muscle and bone strength, and enhancing overall well-being. Treatment success depends heavily on accurate diagnosis and careful consideration of each patient's unique situation.

The approach to treating this condition varies based on the underlying cause, the severity of symptoms, and the patient's age and overall health. In some cases, addressing lifestyle factors or underlying medical conditions can help restore testosterone naturally. When these measures aren't sufficient, medical intervention becomes necessary. Healthcare providers recommend treatment only when both low testosterone levels and clear symptoms are present together.

Before starting any treatment, doctors must confirm the diagnosis through multiple blood tests taken in the morning, when testosterone levels are typically highest. This careful diagnostic process helps ensure that treatment is truly needed and appropriate. The American Urology Association considers testosterone levels below 300 nanograms per deciliter to be low, though this threshold is sometimes debated among specialists.

Treatment decisions should involve shared decision-making between patients and doctors. This means discussing the potential benefits, understanding possible risks, and considering how treatment fits into the patient's life goals. Some men may benefit significantly from therapy, while others with borderline levels and minimal symptoms might not need intervention at all.

Standard Medical Treatment Options

Testosterone replacement therapy is the cornerstone of standard treatment when low testosterone cannot be corrected by addressing underlying causes. This therapy works by supplementing the body's natural testosterone production through external sources, bringing levels back to normal ranges and alleviating symptoms. Treatment typically continues long-term, as stopping therapy usually causes testosterone levels to drop again.

Several delivery methods exist for testosterone replacement, each with its own advantages and considerations. Patches applied to the skin once daily release small amounts of hormone throughout the day, mimicking the body's natural rhythm. However, they can sometimes cause skin irritation at the application site. Gels and creams are applied daily to the shoulders, arms, or abdomen, where the testosterone is absorbed through the skin. These require careful hand washing afterward to prevent accidental transfer to others, especially women and children.

Intramuscular injections of testosterone enanthate or testosterone cypionate are given every one to two weeks in a doctor's office or can be self-administered at home after proper training. These injections cause testosterone levels to rise quickly, then gradually decline before the next dose. Some patients prefer this method because they don't need to remember daily applications, though the fluctuating levels can sometimes cause mood or energy changes.

Implantable pellets, marketed under names like TESTOPEL, are small cylinders inserted under the skin during a minor office procedure. These pellets slowly release testosterone over three to six months, providing steady levels without daily attention. Intranasal sprays and oral formulations also exist, though traditional oral testosterone tablets are rarely used due to concerns about liver effects and inconsistent hormone levels.

When a specific underlying cause is identified, treatment targets that root problem rather than simply replacing testosterone. For example, if excessive hormone production from the pituitary gland is causing low testosterone, medications or surgery might correct the pituitary issue. Similarly, treating obesity, improving diabetes control, or adjusting medications that interfere with testosterone production can sometimes restore normal levels naturally.

The duration of therapy varies by individual. Most men who begin testosterone replacement continue it indefinitely, as the underlying problem with testosterone production typically doesn't resolve on its own. Regular monitoring is essential throughout treatment to ensure effectiveness and watch for complications. Blood tests to measure testosterone levels, complete blood counts to check for elevated red blood cells, and prostate-specific antigen testing are typically performed several times during the first year and annually thereafter.

Potential side effects of testosterone replacement require careful attention. Some men develop polycythemia, an increase in red blood cell count that can thicken the blood and raise the risk of blood clots. Skin reactions at application sites are common with patches and gels. Testosterone can worsen sleep apnea in some individuals. Testicular shrinkage and reduced sperm production may occur, affecting fertility. Mood changes, including increased irritability or aggression, have been reported by some patients.

Cardiovascular risks associated with testosterone therapy remain a subject of ongoing debate and research. The U.S. Food and Drug Administration issued warnings about potential cardiovascular complications, though the exact risk level isn't fully understood. Some studies suggest increased risk of heart problems, while others show neutral or even protective effects. This uncertainty makes it crucial for patients to discuss cardiovascular health thoroughly with their doctors before starting therapy.

Clinical guidelines from organizations like the American Urological Association and the Endocrine Society emphasize that testosterone therapy should only be prescribed when both laboratory evidence of deficiency and consistent symptoms are present. These guidelines recommend against treating men who simply have low levels due to aging without bothersome symptoms. They also stress the importance of accurate testosterone measurement using reliable laboratory methods and properly established reference ranges.

Emerging Treatments in Clinical Research

While standard testosterone replacement remains the primary treatment approach, research into alternative and complementary therapies continues. Clinical trials explore new formulations, delivery methods, and strategies to address testosterone deficiency more effectively or with fewer side effects. However, the sources provided do not contain specific information about experimental drugs, novel therapies, or clinical trials testing innovative treatments for testosterone deficiency syndrome.

Current research efforts focus on understanding the long-term safety profile of testosterone therapy, particularly regarding cardiovascular and prostate health. Studies are examining which patient populations benefit most from treatment and investigating optimal testosterone target levels. Researchers are also working to develop better diagnostic tools that can distinguish between men who truly need therapy and those whose low levels don't require intervention.

Interest exists in therapies that might stimulate the body's own testosterone production rather than replacing it externally. Such approaches could potentially preserve fertility and testicular function better than standard replacement. However, these strategies remain investigational, and their effectiveness and safety profiles are not yet well established through rigorous clinical trials.

Most Common Treatment Methods

  • Testosterone Replacement Therapy
    • Patches applied to skin once daily that release testosterone gradually throughout the day
    • Gels and creams applied daily to shoulders, arms, or abdomen for absorption through skin
    • Intramuscular injections of testosterone enanthate or cypionate given every one to two weeks
    • Implantable pellets inserted under the skin that release testosterone over three to six months
    • Intranasal sprays applied inside the nose
    • Oral testosterone undecanoate formulations absorbed through the lymphatic system
  • Treating Underlying Causes
    • Medications or surgery to correct pituitary gland disorders causing hormone imbalances
    • Weight loss programs for obese patients, as fat cells convert testosterone to estrogen
    • Improved diabetes management to address metabolic factors affecting testosterone production
    • Medication adjustments when certain drugs interfere with testosterone levels
  • Lifestyle Modifications
    • Weight management through diet and exercise to reduce body fat that converts testosterone to estrogen
    • Stress reduction techniques, as chronic stress can lower testosterone production
    • Treatment of sleep apnea, which is associated with lower testosterone levels
    • Avoidance of excessive alcohol consumption and management of chronic illnesses

Did you know?

  1. Testosterone levels naturally decline about 1% to 2% per year starting in a man's 40s, but unlike female menopause, this decline is gradual and not inevitable, which is why the term "male menopause" or "andropause" is considered inaccurate.
  2. Despite testosterone levels influencing approximately 70% of healthcare decisions, only 3 to 5% of healthcare budgets are allocated to diagnostic services, highlighting a significant gap in healthcare resource distribution.
  3. Testosterone deficiency is significantly underdiagnosed and undertreated, with prevalence ranging from 6% to 9.5% in community-dwelling men aged 40 to 70 years, rising to 15% to 30% in diabetic or obese men, yet less than 10% of men with the condition receive treatment.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.